Deep RNA sequencing analysis of readthrough gene fusions in human prostate adenocarcinoma and reference samples
2011

Deep RNA Sequencing Analysis of Gene Fusions in Prostate Cancer

Sample size: 54 publication 10 minutes Evidence: high

Author Information

Author(s): Nacu Serban, Yuan Wenlin, Kan Zhengyan, Bhatt Deepali, Rivers Celina Sanchez, Stinson Jeremy, Peters Brock A, Modrusan Zora, Jung Kenneth, Seshagiri Somasekar, Wu Thomas D

Primary Institution: Genentech, Inc.

Hypothesis

Can deep RNA sequencing effectively identify transcription-induced chimeras (TICs) in prostate adenocarcinoma?

Conclusion

The study found that deep transcriptional sequencing can effectively identify a wide range of TIC events in prostate cancer, revealing more gene pairs than previously estimated.

Supporting Evidence

  • 339 distinct TIC events were identified, increasing the catalog of observed TIC gene pairs by 66%.
  • Expression of TICs correlates with that of the upstream gene.
  • The false discovery rate was estimated to be 1.5%.

Takeaway

Researchers used advanced sequencing to find new gene fusions in prostate cancer, showing that many more genes are involved than we thought before.

Methodology

Single-end RNA-Seq was performed on prostate adenocarcinoma samples and normal tissues, with bioinformatics methods developed to identify TIC events.

Potential Biases

Potential false positives due to sequence similarity among homologous genes.

Limitations

The study focused only on adjacent gene fusions and did not explore fusions between genes on opposite strands or those skipping intervening genes.

Participant Demographics

Three human prostate adenocarcinoma samples and their corresponding normal tissues.

Statistical Information

P-Value

1.5%

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1755-8794-4-11

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication